Mizutani, K., Hara, M., Nakao, M., Okai, T., Kajio, K., Murakami, T., . . . Hayashida, K. (2018). Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan. BMJ Open.
シカゴスタイル引用形Mizutani, Kazuki, et al. "Is Elevation of N-terminal Pro-B-type Natriuretic Peptide At Discharge Associated With 2-year Composite Endpoint of All-cause Mortality and Heart Failure Hospitalisation After Transcatheter Aortic Valve Implantation? Insights From a Multicentre Prospective OCEAN-TAVI Registry in Japan." BMJ Open 2018.
MLA引用形式Mizutani, Kazuki, et al. "Is Elevation of N-terminal Pro-B-type Natriuretic Peptide At Discharge Associated With 2-year Composite Endpoint of All-cause Mortality and Heart Failure Hospitalisation After Transcatheter Aortic Valve Implantation? Insights From a Multicentre Prospective OCEAN-TAVI Registry in Japan." BMJ Open 2018.